Screener
Pulse Biosciences, Inc. PLSE EBITDA
Discontinued — last reported Q2 '26
EBITDA at other companies
Other financials
Where this comes from
Calculated from Pulse Biosciences, Inc.’s reported figures.
The source filing: Pulse Biosciences, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:23 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001437749-26-026288
FAQ
- What is Pulse Biosciences, Inc.'s EBITDA?
- Pulse Biosciences, Inc. (PLSE) reported EBITDA of -$25.02M in Q2 2026.
- How has Pulse Biosciences, Inc.'s EBITDA changed year-over-year?
- Pulse Biosciences, Inc.'s EBITDA decreased by 25.0% year-over-year, from -$20.01M to -$25.02M.
- What is the long-term trend for Pulse Biosciences, Inc.'s EBITDA?
- Over 4 years (2021 to 2025), Pulse Biosciences, Inc.'s EBITDA has grown at a 5.2% compound annual growth rate (CAGR), from -$61.9M to -$75.86M.
- What does EBITDA mean?
- Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.
Ask your AI about Pulse Biosciences, Inc.'s ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude